bpc-157 human clinical trials safety adverse events 🧵a few months ago i started looking at bpc-157. my research showed me that while there is very little evidence to show it works, there's even less to show it's safe Peptide BPC-157 - Does It

Results tend to be most impressive for acute soft tissue injuries less than 6 months old, while chronic structural damage may respond more slowly or incompletely

They are supplied strictly for laboratory and academic research and are not for human consumption, diagnosis, or treatment

NextGenPeps supplies AOD9604 as a high purity research peptide intended strictly for controlled laboratory use in vitro or in established animal models, such as murine systems

They noted that this remote OCT enables earlier detection of disease reactivation, timely as-needed treatment, and prevention of irreversible vision loss, thereby preserving patients' vision and quality of life

A landmark 2007 study published in the Journal of Investigative Dermatology found that AHK-Cu at concentrations between 10 and 10 M stimulated dermal papilla cell (DPC) proliferation, elongated human hair follicles ex vivo, and shifted the Bcl-2/Bax ratio in favor of cell survival meaning fewer follicle cells died prematurely [2]